A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus.
Tatlican
Semih
S
Eren
Cemile
C
Atacan
Damla
D
Dalgic
Umut
U
Canpolat
Filiz
F
Eskioglu
Fatma
F
D000279:Administration, Cutaneous; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006562:Herpes Zoster / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy*; D008875:Middle Aged; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus